| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4171024
Max Phase: Preclinical
Molecular Formula: C23H21N3O2S
Molecular Weight: 403.51
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCCN1C(=O)/C(=N\C(=S)NCc2cc3ccccc3cc2O)c2ccccc21
Standard InChI: InChI=1S/C23H21N3O2S/c1-2-11-26-19-10-6-5-9-18(19)21(22(26)28)25-23(29)24-14-17-12-15-7-3-4-8-16(15)13-20(17)27/h3-10,12-13,27H,2,11,14H2,1H3,(H,24,29)/b25-21-
Standard InChI Key: GRBBZVKJQNEWDO-DAFNUICNSA-N
Associated Targets(Human)
ACE Tclin Angiotensin-converting enzyme (1423 Activities)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 403.51 | Molecular Weight (Monoisotopic): 403.1354 | AlogP: 4.17 | #Rotatable Bonds: 4 |
| Polar Surface Area: 64.93 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 9.00 | CX Basic pKa: | CX LogP: 4.43 | CX LogD: 4.42 |
| Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.64 | Np Likeness Score: -0.89 |
References
| 1. Manikandan A, Moharil P, Sathishkumar M, Muñoz-Garay C, Sivakumar A.. (2017) Therapeutic investigations of novel indoxyl-based indolines: A drug target validation and Structure-Activity Relationship of angiotensin-converting enzyme inhibitors with cardiovascular regulation and thrombolytic potential., 141 [PMID:29032034] [10.1016/j.ejmech.2017.09.076] |
Source
Source(1):